Celestica (TSX:CLS) reported quarterly earnings of $0.52 per share which missed the analyst consensus estimate of $0.62 by 16.13 percent. This is a 48.57 percent increase over earnings of $0.35 per share from the same period last year.
Cidara Therapeutics And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by around 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
